CAM
PFE icon

Costello Asset Management’s Pfizer PFE Stock Holding History

Costello Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Sell
60,897
-6,159
-9% -$161K 0.44% 40
2026
Q1 		$1.88M Sell
67,056
-1,953
-3% -$52K 0.65% 32
2025
Q4 		$1.72M Sell
69,009
-6,202
-8% -$156K 0.57% 33
2025
Q3 		$1.92M Sell
75,211
-5,738
-7% -$142K 0.64% 33
2025
Q2 		$1.96M Sell
80,949
-4,594
-5% -$107K 0.74% 33
2025
Q1 		$2.17M Buy
85,543
+8,643
+11% +$226K 0.88% 27
2024
Q4 		$2.04M Buy
76,900
+19,975
+35% +$542K 1.35% 24
2024
Q3 		$1.65M Buy
56,925
+46,795
+462% +$1.37M 1.1% 31
2024
Q2 		$283K Hold
10,130
– – 0.21% 50
2024
Q1 		$281K Hold
10,130
– – 0.2% 49
2023
Q4 		$292K Sell
10,130
-3,129
-24% -$94.6K 0.24% 51
2023
Q3 		$440K Sell
13,259
-1,068
-7% -$37.8K 0.4% 40
2023
Q2 		$525K Sell
14,327
-2,199
-13% -$85.6K 0.45% 38
2023
Q1 		$674K Buy
16,526
+1,282
+8% +$55.4K 0.69% 35
2022
Q4 		$781K Buy
15,244
+102
+0.7% +$4.89K 0.7% 36
2022
Q3 		$663K Sell
15,142
-346
-2% -$16.8K 0.63% 38
2022
Q2 		$812K Sell
15,488
-77
-0.5% -$3.92K 0.7% 36
2022
Q1 		$806K Sell
15,565
-697
-4% -$36.2K 0.55% 39
2021
Q4 		$960K Sell
16,262
-10,470
-39% -$519K 0.59% 37
2021
Q3 		$1.15M Sell
26,732
-90
-0.3% -$3.99K 0.74% 33
2021
Q2 		$1.05M Sell
26,822
-29,099
-52% -$1.13M 0.69% 33
2021
Q1 		$2.03M Sell
55,921
-889
-2% -$31.6K 1.4% 24
2020
Q4 		$2.09M Sell
56,810
-4,682
-8% -$172K 1.58% 22
2020
Q3 		$2.14M Sell
61,492
-1,160
-2% -$40.7K 1.88% 22
2020
Q2 		$1.94M Buy
+62,652
New +$2.13M 1.91% 20
2019
Q3 		$2.25M Buy
65,906
+640
+1% +$23.3K 2.68% 15
2019
Q2 		$2.68M Buy
65,266
+30,232
+86% +$1.2M 3.05% 14
2019
Q1 		$1.41M Buy
35,034
+267
+0.8% +$10.7K 1.69% 19
2018
Q4 		$1.44M Buy
+34,767
New +$1.44M 1.86% 16

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Costello Asset Management's PFE Position: Q2 2026 in Review

Costello Asset Management reduced its Pfizer (PFE) stake by 9.2% in Q2 2026, selling an estimated $161K and leaving 60,897 shares worth $1.47M. The position accounts for 0.44% of the portfolio, ranked #40.

Costello Asset Management first reported a position in PFE in Q4 2018 and has held it in 29 quarters since. The position peaked at $2.68M in Q2 2019. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Costello Asset Management held 60,897 shares of Pfizer worth $1.47M as of Q2 2026.
  • Costello Asset Management sold 6,159 Pfizer shares in Q2 2026, an estimated $161K.
  • Pfizer made up 0.44% of Costello Asset Management's portfolio in Q2 2026, its #40 holding.
  • Costello Asset Management first reported a position in Pfizer in Q4 2018 and has held it in 29 quarters since.
  • Costello Asset Management's Pfizer position peaked at $2.68M in Q2 2019.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Costello Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.